SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer.
Koller S, Kendler J, Karacs J, Wolf A, Kreuzinger C, Von Der Decken I, Mungenast F, Mechtcheriakova D, Schreiner W, Gleiss A, Jäger W, Cacsire Castillo-Tong D, Thalhammer T.
Koller S, et al. Among authors: jager w.
Front Pharmacol. 2022 Aug 29;13:946348. doi: 10.3389/fphar.2022.946348. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36105223
Free PMC article.